October 2026
- Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
- Spinal Tuberculosis
- What I See before Anyone Speaks
- Why Shared-Savings ACOs Have Failed to Deliver for Primary Care
- Community Engagement Requirements in Medicaid — Law as a Determinant of Health
- Case 29-2026: A 39-Year-Old Man with Abdominal Pain, Foot Drop, and a Spinal Mass
- Alkaptonuria
- Chemotherapy-free Treatment of Ph-Positive ALL
- Adapting to Genomic Medicine
- Integration-Associated Paraspinal Neoplasm after AAV Gene Therapy
- Once-Weekly Mosnodenvir as Dengue Prophylaxis in a Human Infection Model
- Setmelanotide for the Treatment of Acquired Hypothalamic Obesity
- Extended DAPT for Multivessel Coronary Artery Disease
- Obinutuzumab in Active Systemic Lupus Erythematosus
- Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis
- Long-Acting HIV Therapy in African Adults with Adherence Challenges
- Ponatinib–Blinatumomab or Imatinib–Chemotherapy for Adult Ph-Positive ALL
- Adult Attention Deficit–Hyperactivity Disorder
- Continuous Glucose Monitoring in Non–Insulin-Treated Type 2 Diabetes
- Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury
- Continuous or Intermittent Renal-Replacement Therapy — What Is the Question?
- Flushing in Carcinoid Syndrome
- Health-Related Social Needs among Older Adults — Addressing Mismeasurement
- Not Available in Your Country
- Who Counts as Infertile? A Missed Opportunity for Inclusion
- Firearm-Related Discussions as an Age-Friendly Intervention
- Clinical Trial Prediction Markets — Information, at What Cost?
- Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes
- Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
- IARC Perspective on Lung Cancer Screening
- Short or Long Antibiotic Regimens in Orthopedics
- Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
- Reengineering Coagulation with a Bispecific Antibody
- Tozorakimab to Prevent COPD Exacerbations
- Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
- Immediate Ambulatory Electrocardiographic Monitoring in Syncope
- Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
- Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension
- Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients
- The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome
- Prasugrel versus Ticagrelor in Acute Coronary Syndromes
- Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI
- Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
- Prevalence of Silent Atherosclerosis across Adult Life
- Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain
- Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
- Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis
- Eplontersen for Transthyretin Amyloid Cardiomyopathy
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
- Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.